United Kingdom (UK) Haemophilia Market (2025-2031) | Industry, Value, Growth, Segmentation, Share, Companies, Forecast, Outlook, Analysis, Size & Revenue, Trends, Competitive Landscape

Market Forecast By Treatment (Medication, Desmopressin, Emicizumab, Anti-fibrinolytics, ITI Therapy, Gene Therapy, Fibrin Sealants, Others), By Route of Administration (Oral, Injectable, Others), By Diagnosis (Blood Test, Genetic Tests, Others), By Patient (Pediatric, Adult), By Type (Haemophilia A, Haemophilia B, Haemophilia C, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) And Competitive Landscape
Product Code: ETC9945661 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Vasudha No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) Haemophilia Market Outlook
  • Market Size of United Kingdom (UK) Haemophilia Market, 2024
  • Forecast of United Kingdom (UK) Haemophilia Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) Haemophilia Market Trend Evolution
  • United Kingdom (UK) Haemophilia Market Drivers and Challenges
  • United Kingdom (UK) Haemophilia Price Trends
  • United Kingdom (UK) Haemophilia Porter's Five Forces
  • United Kingdom (UK) Haemophilia Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Treatment for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Medication for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Desmopressin for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Emicizumab for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Anti-fibrinolytics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By ITI Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Gene Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Fibrin Sealants for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Medication Haemophilia Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Injectable for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Diagnosis for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Blood Test for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Genetic Tests for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Patient for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Pediatric for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Adult for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Type for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Haemophilia A for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Haemophilia B for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Haemophilia C for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By End-Users for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Homecare for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Haemophilia Market Revenues & Volume By Others for the Period 2021- 2031
  • United Kingdom (UK) Haemophilia Import Export Trade Statistics
  • Market Opportunity Assessment By Treatment
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Diagnosis
  • Market Opportunity Assessment By Patient
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By End-Users
  • Market Opportunity Assessment By Distribution Channel
  • United Kingdom (UK) Haemophilia Top Companies Market Share
  • United Kingdom (UK) Haemophilia Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Haemophilia Company Profiles
  • United Kingdom (UK) Haemophilia Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United Kingdom (UK) Haemophilia Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) Haemophilia Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Haemophilia Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Haemophilia Market - Industry Life Cycle

3.4 United Kingdom (UK) Haemophilia Market - Porter's Five Forces

3.5 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Treatment, 2021 & 2031F

3.6 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F

3.8 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Patient, 2021 & 2031F

3.9 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Type, 2021 & 2031F

3.10 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.11 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United Kingdom (UK) Haemophilia Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Technological advancements in treatment options for haemophilia

4.2.2 Increasing awareness and diagnosis rates of haemophilia in the UK

4.2.3 Growing research and development activities in the field of haemophilia treatments

4.3 Market Restraints

4.3.1 High cost associated with haemophilia treatment and management

4.3.2 Limited access to specialized healthcare services in certain regions of the UK

4.3.3 Regulatory challenges and compliance requirements in the haemophilia market

5 United Kingdom (UK) Haemophilia Market Trends

6 United Kingdom (UK) Haemophilia Market, By Types

6.1 United Kingdom (UK) Haemophilia Market, By Treatment

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Treatment, 2021- 2031F

6.1.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Medication, 2021- 2031F

6.1.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Desmopressin, 2021- 2031F

6.1.5 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Emicizumab, 2021- 2031F

6.1.6 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Anti-fibrinolytics, 2021- 2031F

6.1.7 United Kingdom (UK) Haemophilia Market Revenues & Volume, By ITI Therapy, 2021- 2031F

6.1.8 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.1.9 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F

6.1.10 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F

6.2 United Kingdom (UK) Haemophilia Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Oral, 2021- 2031F

6.2.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Injectable, 2021- 2031F

6.2.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F

6.3 United Kingdom (UK) Haemophilia Market, By Diagnosis

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Blood Test, 2021- 2031F

6.3.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Genetic Tests, 2021- 2031F

6.3.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F

6.4 United Kingdom (UK) Haemophilia Market, By Patient

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Pediatric, 2021- 2031F

6.4.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Adult, 2021- 2031F

6.5 United Kingdom (UK) Haemophilia Market, By Type

6.5.1 Overview and Analysis

6.5.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Haemophilia A, 2021- 2031F

6.5.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Haemophilia B, 2021- 2031F

6.5.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Haemophilia C, 2021- 2031F

6.5.5 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F

6.6 United Kingdom (UK) Haemophilia Market, By End-Users

6.6.1 Overview and Analysis

6.6.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Hospitals, 2021- 2031F

6.6.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.6.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Homecare, 2021- 2031F

6.6.5 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F

6.7 United Kingdom (UK) Haemophilia Market, By Distribution Channel

6.7.1 Overview and Analysis

6.7.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.7.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.7.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F

6.7.5 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F

7 United Kingdom (UK) Haemophilia Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Haemophilia Market Export to Major Countries

7.2 United Kingdom (UK) Haemophilia Market Imports from Major Countries

8 United Kingdom (UK) Haemophilia Market Key Performance Indicators

8.1 Patient adherence and compliance rates to prescribed haemophilia treatment plans

8.2 Number of clinical trials and research studies conducted in the field of haemophilia in the UK

8.3 Rate of adoption of new haemophilia treatment technologies and therapies in the UK market

9 United Kingdom (UK) Haemophilia Market - Opportunity Assessment

9.1 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Treatment, 2021 & 2031F

9.2 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Diagnosis, 2021 & 2031F

9.4 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Patient, 2021 & 2031F

9.5 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Type, 2021 & 2031F

9.6 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.7 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United Kingdom (UK) Haemophilia Market - Competitive Landscape

10.1 United Kingdom (UK) Haemophilia Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Haemophilia Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Leadership Perspectives from Industry Events

6Wresearch in the News

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Industry Events and Analyst Meet

Whitepaper

Read All